The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125259233 12525923 3 F 20160622 20160718 20160705 20160726 EXP US-JNJFOC-20160622967 JOHNSON AND JOHNSON 38.00 YR A F Y 167.50000 KG 20160726 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125259233 12525923 1 PS APAP/DOXYLAMINE/DEXTROMETHORPHAN ACETAMINOPHENDEXTROMETHORPHAN HYDROBROMIDEDOXYLAMINE SUCCINATE 1 Oral U U 0 UNSPECIFIED
125259233 12525923 2 SS MORPHINE MORPHINE 1 Oral U 0 UNSPECIFIED
125259233 12525923 3 SS OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral U 0 UNSPECIFIED
125259233 12525923 4 SS ALL OTHER THERAPEUTIC PRODUCTS UNSPECIFIED INGREDIENT 1 Oral U 0 UNSPECIFIED
125259233 12525923 5 C MINOCYCLINE MINOCYCLINEMINOCYCLINE HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
125259233 12525923 6 C FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
125259233 12525923 7 C DICLOFENAC DICLOFENAC 1 Unknown 0 UNSPECIFIED
125259233 12525923 8 C NAPROXEN. NAPROXEN 1 Unknown 0 UNSPECIFIED
125259233 12525923 9 C LISINOPRIL. LISINOPRIL 1 Unknown 0 UNSPECIFIED
125259233 12525923 10 C MS CONTIN MORPHINE SULFATE 1 Unknown 0 UNSPECIFIED
125259233 12525923 11 C GABAPENTIN. GABAPENTIN 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125259233 12525923 1 Product used for unknown indication
125259233 12525923 2 Product used for unknown indication
125259233 12525923 3 Product used for unknown indication
125259233 12525923 4 Product used for unknown indication
125259233 12525923 5 Product used for unknown indication
125259233 12525923 6 Product used for unknown indication
125259233 12525923 7 Product used for unknown indication
125259233 12525923 8 Product used for unknown indication
125259233 12525923 9 Product used for unknown indication
125259233 12525923 10 Product used for unknown indication
125259233 12525923 11 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125259233 12525923 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125259233 12525923 Coma
125259233 12525923 Extra dose administered
125259233 12525923 Hypoxia
125259233 12525923 Liver injury
125259233 12525923 Respiratory depression
125259233 12525923 Rhabdomyolysis
125259233 12525923 Toxicity to various agents

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found